Scorpion Toxins Targeting Kv1.3 Channels: Insights into Immunosuppression

Overview

Journal J Venom Anim Toxins Incl Trop Dis

Date 2019 May 28

PMID 31131004

Citations 14

Authors

Isadora S Oliveira

Isabela G Ferreira

Gabriel M Alexandre-Silva

Felipe A Cerni

Caroline M Cremonez

Eliane C Arantes

Umberto Zottich

Manuela B Pucca

Affiliations

Soon will be listed here.

Abstract

Scorpion venoms are natural sources of molecules that have, in addition to their toxic function, potential therapeutic applications. In this source the neurotoxins can be found especially those that act on potassium channels. Potassium channels are responsible for maintaining the membrane potential in the excitable cells, especially the voltage-dependent potassium channels (Kv), including Kv1.3 channels. These channels (Kv1.3) are expressed by various types of tissues and cells, being part of several physiological processes. However, the major studies of Kv1.3 are performed on T cells due its importance on autoimmune diseases. Scorpion toxins capable of acting on potassium channels (KTx), mainly on Kv1.3 channels, have gained a prominent role for their possible ability to control inflammatory autoimmune diseases. Some of these toxins have already left bench trials and are being evaluated in clinical trials, presenting great therapeutic potential. Thus, scorpion toxins are important natural molecules that should not be overlooked in the treatment of autoimmune and other diseases.

Citing Articles

Immunomodulatory effect of sp. in mononuclear cells extracted from the blood of rheumatoid arthritis patients.

Tobar C, Urmendiz Y, Vallejo M, Manquillo D, Castano V, Caicedo A J Venom Anim Toxins Incl Trop Dis. 2024; 30:e20230064.

PMID: 39445068 PMC: 11498904. DOI: 10.1590/1678-9199-JVATITD-2023-0064.

Electrophysiological evaluation of the effect of peptide toxins on voltage-gated ion channels: a scoping review on theoretical and methodological aspects with focus on the Central and South American experience.

Rojas-Palomino J, Gomez-Restrepo A, Salinas-Restrepo C, Segura C, Giraldo M, Calderon J J Venom Anim Toxins Incl Trop Dis. 2024; 30:e20230048.

PMID: 39263598 PMC: 11389830. DOI: 10.1590/1678-9199-JVATITD-2023-0048.

Scorpion Peptides and Ion Channels: An Insightful Review of Mechanisms and Drug Development.

Mendes L, Viana G, Abrahao Nencioni A, Pimenta D, Beraldo-Neto E Toxins (Basel). 2023; 15(4).

PMID: 37104176 PMC: 10145618. DOI: 10.3390/toxins15040238.

Recombinant expression and antigenicity of two peptide families of neurotoxins from sp.

Cardoso-Arenas S, Clement H, Arenas I, Olvera F, Zamudio F, Caliskan F J Venom Anim Toxins Incl Trop Dis. 2022; 28:e20220026.

PMID: 36578820 PMC: 9769139. DOI: 10.1590/1678-9199-JVATITD-2022-0026.

Anti-Cancer Activity of Venom on Hepatocellular Carcinoma in 3D Cell Culture.

Lafnoune A, Lee S, Heo J, Daoudi K, Darkaoui B, Chakir S Molecules. 2022; 27(7).

PMID: 35408621 PMC: 9000837. DOI: 10.3390/molecules27072219.

References

Tytgat J, Chandy K, Garcia M, Gutman G, Martin-Eauclaire M, Van der Walt J . A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol Sci. 1999; 20(11):444-7. DOI: 10.1016/s0165-6147(99)01398-x. View

Kotecha S, Schlichter L . A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation. J Neurosci. 1999; 19(24):10680-93. PMC: 6784954. View

Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish R . Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J Investig Dermatol Symp Proc. 2000; 4(3):207-10. DOI: 10.1038/sj.jidsp.5640212. View

Cayabyab F, Khanna R, Jones O, Schlichter L . Suppression of the rat microglia Kv1.3 current by src-family tyrosine kinases and oxygen/glucose deprivation. Eur J Neurosci. 2000; 12(6):1949-60. DOI: 10.1046/j.1460-9568.2000.00083.x. View

Ghanshani S, Wulff H, Miller M, Rohm H, Neben A, Gutman G . Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem. 2000; 275(47):37137-49. DOI: 10.1074/jbc.M003941200. View

Christophers E . Psoriasis--epidemiology and clinical spectrum. Clin Exp Dermatol. 2001; 26(4):314-20. DOI: 10.1046/j.1365-2230.2001.00832.x. View

Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M, Bernard D . Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U S A. 2001; 98(24):13942-7. PMC: 61146. DOI: 10.1073/pnas.241497298. View

Choe S . Potassium channel structures. Nat Rev Neurosci. 2002; 3(2):115-21. DOI: 10.1038/nrn727. View

Viglietta V, Kent S, Orban T, Hafler D . GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest. 2002; 109(7):895-903. PMC: 150925. DOI: 10.1172/JCI14114. View

10.

Huys I, Dyason K, Waelkens E, Verdonck F, van Zyl J, Plessis J . Purification, characterization and biosynthesis of parabutoxin 3, a component of Parabuthus transvaalicus venom. Eur J Biochem. 2002; 269(7):1854-65. DOI: 10.1046/j.1432-1033.2002.02833.x. View

11.

Srinivasan K, Sivaraja V, Huys I, Sasaki T, Cheng B, Kumar T . kappa-Hefutoxin1, a novel toxin from the scorpion Heterometrus fulvipes with unique structure and function. Importance of the functional diad in potassium channel selectivity. J Biol Chem. 2002; 277(33):30040-7. DOI: 10.1074/jbc.M111258200. View

12.

Wickenden A . K(+) channels as therapeutic drug targets. Pharmacol Ther. 2002; 94(1-2):157-82. DOI: 10.1016/s0163-7258(02)00201-2. View

13.

Varambally S, Dhanasekaran S, Zhou M, Barrette T, Kumar-Sinha C, Sanda M . The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002; 419(6907):624-9. DOI: 10.1038/nature01075. View

14.

Batista C, Gomez-Lagunas F, Rodriguez de la Vega R, Hajdu P, Panyi G, Gaspar R . Two novel toxins from the Amazonian scorpion Tityus cambridgei that block Kv1.3 and Shaker B K(+)-channels with distinctly different affinities. Biochim Biophys Acta. 2002; 1601(2):123-31. DOI: 10.1016/s1570-9639(02)00458-2. View

15.

Coronas F, de Roodt A, Portugal T, Zamudio F, Batista C, Gomez-Lagunas F . Disulfide bridges and blockage of Shaker B K(+)-channels by another butantoxin peptide purified from the Argentinean scorpion Tityus trivittatus. Toxicon. 2003; 41(2):173-9. DOI: 10.1016/s0041-0101(02)00247-7. View

16.

Xu J, Koni P, Wang P, Li G, Kaczmarek L, Wu Y . The voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight. Hum Mol Genet. 2003; 12(5):551-9. DOI: 10.1093/hmg/ddg049. View

17.

Pimenta A, Mansuelle P, DINIZ C, Martin-Eauclaire M . Covalent structure and some pharmacological features of native and cleaved alpha-KTx12-1, a four disulfide-bridged toxin from Tityus serrulatus venom. J Pept Sci. 2003; 9(2):132-40. DOI: 10.1002/psc.440. View

18.

Gilhar A, Landau M, Assy B, Ullmann Y, Shalaginov R, Serafimovich S . Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. Clin Immunol. 2003; 106(3):181-7. DOI: 10.1016/s1521-6616(02)00042-6. View

19.

Wulff H, Calabresi P, Allie R, Yun S, Pennington M, Beeton C . The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest. 2003; 111(11):1703-13. PMC: 156104. DOI: 10.1172/JCI16921. View

20.

van den Ouweland J, Lemkes H, Ruitenbeek W, Sandkuijl L, de Vijlder M, Struyvenberg P . Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet. 1992; 1(5):368-71. DOI: 10.1038/ng0892-368. View